Makoto Fukuda

Dr. Makoto Fukuda

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1997 in Nature
Verified
Journal Article
Closed access
MFMakoto Fukuda
Makoto Fukuda
SAShiro Asano
Shiro Asano
TNTakahiro Nakamura
Takahiro Nakamura
MAMakoto Adachi
Makoto Adachi
MYMinoru Yoshida
Minoru Yoshida
ENEisuke Nishida
Eisuke Nishida

15 February 1998 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MYMitsutoshi Yoneyama
Mitsutoshi Yoneyama
WSWakako Suhara
Wakako Suhara
YFYukiko Fukuhara
Yukiko Fukuhara
MFMakoto Fukuda
Makoto Fukuda
ENEisuke Nishida
Eisuke Nishida
TFTakashi Fujita
Takashi Fujita
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 April 2010 in Cell Metabolism
Verified
Journal Article
Closed access
Jennifer HillJennifer Hill
Jennifer Hill
CECarol F. Elias
Carol F. Elias
MFMakoto Fukuda
Makoto Fukuda
KWKevin W. Williams
Kevin W. Williams
EBEric D. Berglund
Eric D. Berglund
JEJoel K. Elmquist
Joel K. Elmquist

15 April 1997 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MFMakoto Fukuda
Makoto Fukuda
YGYukiko Gotoh
Yukiko Gotoh
ENEisuke Nishida
Eisuke Nishida
The mitogen‐activated protein kinase (MAPK) cascade consisting of MAPK and its direct activator, MAPK kinase (MAPKK), is essential for signaling of various extracellular stimuli to the nucleus. Upon stimulation, MAPK is translocated to the nucleus, whereas MAPKK stays in the cytoplasm. It has been shown recently that the cytoplasmic localization of MAPKK is determined by its nuclear export signal (NES) in the near N‐terminal region (residues 33–44). However, the mechanism determining the subcellular distribution of MAPK has been poorly understood. Here, we show that introduction of v‐Ras, active STE11 or constitutively active MAPKK can induce nuclear translocation of MAPK in mammalian cultured cells. Furthermore, we show evidence suggesting that MAPK is localized to the cytoplasm through its specific association with MAPKK and that nuclear accumulation of MAPK is accompanied by dissociation of a complex between MAPK and MAPKK following activation of the MAPK pathway. We have identified the MAPK‐binding site of MAPKK as its N‐terminal residues 1–32. Moreover, a peptide encompassing the MAPK‐binding site and the NES sequence of MAPKK has been shown to be sufficient to retain MAPK to the cytoplasm. These findings reveal the molecular basis regulating subcellular distribution of MAPK, and identify a novel function of MAPKK as a cytoplasmic anchoring protein for MAPK.

1 August 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MFMakoto Fukuda
Makoto Fukuda
IGIsamu Gotoh
Isamu Gotoh
YGYukiko Gotoh
Yukiko Gotoh
ENEisuke Nishida
Eisuke Nishida
Mitogen-activated protein kinase (MAPK) is activated in cytoplasm in response to extracellular signals and then is translocated to nucleus. A directed activator for MAPK, MAPK kinase (MAPKK), stays in cytoplasm to transmit the signal from the plasma membrane to MAPK. Here we show that MAPKK contains a short amino acid sequence in the N-terminal region (residues 32-44), which acts as a nuclear export signal (NES) and thus is required for cytoplasmic localization of MAPKK. This NES sequence of MAPKK, like that of protein kinase inhibitor of cAMP-dependent protein kinase or Rev, is rich in leucine residues, which are crucial for the NES activity. Furthermore, the NES peptide of protein kinase inhibitor, as well as the NES peptide of MAPKK, inhibited the nuclear export of ovalbumin conjugated to the NES peptide of MAPKK. These results may suggest a common mechanism of nuclear export using a general leucine-rich NES.

12 May 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
LJLin Jia
Lin Jia
CVClaudia R. Vianna
Claudia R. Vianna
MFMakoto Fukuda
Makoto Fukuda
EBEric D. Berglund
Eric D. Berglund
CLChen Liu
Chen Liu
JEJoel K. Elmquist
Joel K. Elmquist
Chronic low-grade inflammation is a hallmark of obesity and thought to contribute to the development of obesity-related insulin resistance. Toll-like receptor 4 (Tlr4) is a key mediator of pro-inflammatory responses. Mice lacking Tlr4s are protected from diet-induced insulin resistance and inflammation; however, which Tlr4-expressing cells mediate this effect is unknown. Here we show that mice deficient in hepatocyte Tlr4 (Tlr4LKO) exhibit improved glucose tolerance, enhanced insulin sensitivity and ameliorated hepatic steatosis despite the development of obesity after a high-fat diet (HFD) challenge. Furthermore, Tlr4LKO mice have reduced macrophage content in white adipose tissue, as well as decreased tissue and circulating inflammatory markers. In contrast, the loss of Tlr4 activity in myeloid cells has little effect on insulin sensitivity. Collectively, these data indicate that the activation of Tlr4 on hepatocytes contributes to obesity-associated inflammation and insulin resistance, and suggest that targeting hepatocyte Tlr4 might be a useful therapeutic strategy for the treatment of type 2 diabetes.